Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) announced that recently, Beijing Shengdi Pharmaceutical Co., Ltd., a subsidiary of the company, received a notice from the State Drug Administration to approve the launch of a Class 1 new drug independently developed by the company.

Zhitongcaijing · 4d ago
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) announced that recently, Beijing Shengdi Pharmaceutical Co., Ltd., a subsidiary of the company, received a notice from the State Drug Administration to approve the launch of a Class 1 new drug independently developed by the company.